Using a molecular scissors to improve CAR-T cell therapy

13 September 2024 1 min read

Estimated reading time: 1 minutes

About The Author

Researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients.

About The Author

See author's posts

Post Views: 1

Discover more from Life is Pro-Mazing!

Subscribe to get the latest posts sent to your email.

Leave a ReplyCancel reply

Related Stories

FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology

Lower neighborhood opportunity may increase risk for preterm birth

New treatment extends ovarian function in older mice

You may have missed

FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology

Lower neighborhood opportunity may increase risk for preterm birth

New treatment extends ovarian function in older mice

Getting to the root of the problem: Intensive diabetes treatment reduces gum disease inflammation

About The Author

Like this:

Related

Discover more from Life is Pro-Mazing!

Leave a ReplyCancel reply

Related Stories

FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology

Lower neighborhood opportunity may increase risk for preterm birth

New treatment extends ovarian function in older mice

You may have missed

FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology

Lower neighborhood opportunity may increase risk for preterm birth

New treatment extends ovarian function in older mice

Getting to the root of the problem: Intensive diabetes treatment reduces gum disease inflammation

Discover more from Life is Pro-Mazing!